Dublin, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The "Consumer DNA (Genetic) Testing Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering.
The Global Consumer DNA (Genetic) Testing Market will soar from USD 1.81 billion in 2025 to USD 3.16 billion in 2030, with an 11.76% compound annual growth rate (CAGR).
The global consumer DNA (genetic) testing market is experiencing accelerated growth, propelled by escalating demand for direct-to-consumer (DTC) services, identity exploration, and ancestry insights. These tests analyze chromosomal, genetic, and protein variations to assess disease risks, rule out conditions, or uncover familial heritage. Key drivers include heightened public awareness of technological advancements and substantial investments by leading firms in innovative DTC solutions.
Major players like Ancestry and 23andMe are channeling resources into superior testing platforms, enhancing accuracy and user accessibility. The expansion of genetic ancestry testing, which extends beyond historical records to reveal deep genealogical connections via cheek swabs or saliva kits, is a pivotal force. This segment's appeal lies in its entertainment value and potential for discovering hidden family ties, fostering broader market penetration.
Market Drivers
Surge in Genetic Ancestry Testing
Genetic ancestry testing represents a cornerstone of market expansion, enabling individuals to trace lineage and ethnic origins with unprecedented precision. Demand has surged particularly in Europe and North America, where consumers seek affordable, at-home kits priced competitively to democratize access. These tests, often costing around US$59, deliver comprehensive reports on heritage, migration patterns, and relative matches, transforming personal curiosity into actionable insights.
Leading providers maintain vast DNA databases, aggregating millions of profiles to refine matching algorithms and expand reference populations. For instance, Ancestry and 23andMe boast some of the world's largest human DNA repositories, facilitating robust ethnicity estimates and family tree integrations.
The DTC model's growth amplifies this trend, empowering users to bypass clinical settings for immediate results. Companies like Gene By Gene and MyHeritage contribute through expansive ancestry databases - encompassing millions of profiles - supporting advanced features such as high-resolution geographic subgrouping across thousands of regions. This innovation not only boosts user engagement but also enhances market share by offering personalized, scientifically grounded narratives.
The merger dynamics among genomics firms, such as those involving myDNA and FamilyTreeDNA, underscore a strategic focus on bolstering scientific foundations for tailored insights, integrating DTC with professional-grade analytics. Such developments signal a maturing ecosystem where ancestry testing intersects with health and wellness applications, driving cross-selling opportunities and sustained revenue growth.
Geographical Outlook
The Asia-Pacific region is poised to capture a substantial market share, fueled by a proliferation of startups and burgeoning enthusiasm for ancestral DNA exploration. Rapid urbanization, rising disposable incomes, and cultural interest in heritage tracing are accelerating adoption, positioning the region as a high-growth hub. This contrasts with established markets in Europe and North America, where mature infrastructure supports premium services, but Asia-Pacific's scalability offers untapped potential for global players.
Market Outlook
The consumer DNA testing market is on a trajectory of robust expansion through 2030, with genetic ancestry as a linchpin for innovation and consumer adoption. Affordable, user-centric kits and expansive databases will continue to lower barriers, while DTC evolution integrates ancestry with predictive health analytics.
Industry experts should monitor regulatory shifts around data privacy and ethical sourcing to mitigate risks. Strategic investments in AI-driven interpretations and regional partnerships will be essential to capitalize on Asia-Pacific's momentum, ensuring sustained differentiation in a competitive landscape dominated by data-rich incumbents.
Report Coverage:
- Historical data from 2022 to 2024 & forecast data from 2025 to 2030
- Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
- Competitive Positioning, Strategies, and Market Share Analysis
- Revenue Growth and Forecast Assessment of segments and regions including countries
- Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 150 |
| Forecast Period | 2025 - 2030 |
| Estimated Market Value (USD) in 2025 | $1.81 Billion |
| Forecasted Market Value (USD) by 2030 | $3.16 Billion |
| Compound Annual Growth Rate | 11.7% |
| Regions Covered | Global |
Key Topics Covered:
1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. GLOBAL CONSUMER DNA (GENETIC) TESTING MARKET BY TYPE
5.1. Introduction
5.2. Carrier Testing
5.3. Ancestry Testing
5.4. Predictive Testing
5.5. Others
6. GLOBAL CONSUMER DNA (GENETIC) TESTING MARKET BY SAMPLE TYPE
6.1. Introduction
6.2. Saliva
6.3. Cheek Swab
6.4. Others
7. GLOBAL CONSUMER DNA (GENETIC) TESTING MARKET BY DISTRIBUTION CHANNEL
7.1. Introduction
7.2. Online
7.3. Offline
8. GLOBAL CONSUMER DNA (GENETIC) TESTING MARKET BY DISTRIBUTION CHANNEL
8.1. Introduction
8.2. Kinship
8.3. Ancestry & Genealogy
8.4. Health & Wellness Testing
8.5. Others
9. GLOBAL CONSUMER DNA (GENETIC) TESTING MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. USA
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. Germany
9.4.2. France
9.4.3. United Kingdom
9.4.4. Italy
9.4.5. Spain
9.4.6. Others
9.5. Middle East and Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Israel
9.5.4. Others
9.6. Asia-Pacific
9.6.1. China
9.6.2. India
9.6.3. Japan
9.6.4. South Korea
9.6.5. Indonesia
9.6.6. Thailand
9.6.7. Taiwan
9.6.8. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Quest Diagnostics Inc.
11.2. Mapmygenome
11.3. Labcorp
11.4. Gene by Gene, Ltd
11.5. Myriad Genetics
11.6. Color Health Inc.
11.7. 23andMe Inc.
11.8. Ancestry
11.9. Veritas Genetics
11.10. Nebula Genomics
For more information about this report visit https://www.researchandmarkets.com/r/yw779y
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
